Below is a spreadsheet that highlights the changes to Francis Chou's
Chou Associates US long stock portfolio as of Q2 2013. For a look at how
his portfolio has progressed, see our previous update:
The only significant buy this quarter was a ~36% stake increase in Resolute Forest Products (RFP) - Francis Chou has been bullish on this name since 2010 when the company was named Abitibibowater. his average cost-basis is much higher. Chou also sold more than half of his stake in Overstock (OSTK) and about 45% of Actavis (ACT). ACT is a very long-term holding (prior to 2007 when it was Watson Pharmaceuticals) and Chou is harvesting large capital gains from this position.
To learn more about how to profit from a strategy of cloning hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .
The only significant buy this quarter was a ~36% stake increase in Resolute Forest Products (RFP) - Francis Chou has been bullish on this name since 2010 when the company was named Abitibibowater. his average cost-basis is much higher. Chou also sold more than half of his stake in Overstock (OSTK) and about 45% of Actavis (ACT). ACT is a very long-term holding (prior to 2007 when it was Watson Pharmaceuticals) and Chou is harvesting large capital gains from this position.
To learn more about how to profit from a strategy of cloning hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .
1 comment :
I appreciate this portfolio update. Normally, I go to gurufocus, but Mr. Chou s portfolio is not available there (for free). From now on I go to here. Thanks.
Post a Comment